|
|
|
|
|
PEER-TO-PEER CLINICAL CONVERSATIONS
|
|
|
|
|
|
|
Integration of Lutetium-177 and the Value of Shared Decisions with Practice Stakeholders
|
Jeffrey Zemencik
Phillip Koo interviews Jeffrey Zemencik about the challenges and considerations of integrating the PLUVICTO® (lutetium Lu 177 vipivotide tetraxetan) treatment into large urology practices. Mr. Zemencik emphasizes the importance of a multi-disciplinary approach, involving stakeholders from various departments like operations and revenue cycle.
|
|
|
|
|
|
|
|
|
|
|
|
Shared Decision-Making vs. Physician or Patient-Directed Decisions on Patient Quality of Life and Decision Satisfaction in Metastatic Prostate Cancer
|
Frank Schumacher
Alicia Morgans is joined by Frank Schumacher to discuss the study results assessing the association of functional outcomes by decision-making approaches in men with metastatic prostate cancer. This work looked at the association of shared decision-making vs. physician- or patient-directed decisions and measurement of patient quality of life, including patient-reported functional outcomes and decision satisfaction. |
|
|
|
|
|
|
|
|
|
|
|
Treatment Decision Making in mCRPC: The Urologist and Patient “What the Patient Needs to Know” About His Disease and Treatment Options?
|
|
Brenda Martone, MSN, ANP-BC, AOCNP
|
In this Beyond Androgen Blockade – New Pathways and Novel Treatments in mHSPC and mCRPC educational video series Brenda Martone addresses insights into the evolving landscape of prostate cancer treatment, focusing on the diverse therapeutic options available, the holistic management of patients, and the crucial role of patient education and adherence in achieving positive outcomes.
|
|
|
|
|
|
|
|
|
|
|
|
| The Intersection of Insurance with Shared Decision-Making for Advanced Prostate Cancer Care |
|
Rand Wilcox Vanden Berg, MD
|
| In this discussion, Ruchika Talwar and Rand Wilcox Vanden Berg delve into the intricacies of patient-physician shared decision-making for advanced prostate cancer treatment, and its intersection with insurance policies.
|
|
|
|
|
|
|
|
|
|
|
|
| Association of Functional Outcomes by Decision-Making Approach in Men with Metastatic Prostate Cancer
|
| Frank Schumacher, MD
|
| Frank Schumacher presents the results assessing the association of functional outcomes by the decision-making approach in men with metastatic prostate cancer. The study involved 101 participants, and the findings suggested that patients reporting greater control during treatment decisions had superior physical functioning and a trend toward greater decision satisfaction at 4 months, highlighting potential benefits from involvement in the decision-making process. |
|
|
|
|
|
| The Impact of F-18 PSMA PET Imaging on Clinical Decision-Making in Prostate Cancer Across Disease States
|
| Ali Arafa, MD
|
| Ali Arafa discussed the impact of F-18 PSMA PET imaging on clinical decision-making in prostate cancer across different disease states. The study, involving 235 patients, revealed that the integration of F-18 PSMA PET imaging significantly influenced clinical decision-making, particularly in the initial staging of high-risk localized disease and biochemical recurrence. Dr. Arafa emphasizes the need for further research to determine if these changes in clinical management translate into superior survival outcomes.
|
|
|
|
|
|
|
|
|
|
|
| Cases in Oligometastatic Prostate Cancer: Partnering for Patient-Centered Care
|
| Shekinah Elmore, MD, MPH
|
| Shekinah Elmore discusses cases in oligometastatic prostate cancer and highlights the importance of patient-centered care. The presentation focuses on the "Four Ps" – patient goals and values, patient-reported outcomes and quality of life, prognostication, and palliative and supportive interventions. Dr. Elmore discusses two cases, emphasizing individualized treatment approaches, patient preferences, and the significance of language in communicating with patients about their prognosis and treatment options. |
|
|
|
|
|
| Management of Prostate Cancer in Older Adults: Assessment and Decision Tools for Balancing Survival and Quality of Life
|
| Elizabeth Kessler, MD
|
| Elizabeth Kessler discusses the management of prostate cancer in older adults, emphasizing the importance of assessing and balancing survival and quality of life. She highlights the unique characteristics of the elderly population, including common challenges and considerations such as multiple medical problems, fixed income, and concerns about being a burden to others.
|
|
|
|
|
|
|
